E-Prescribing Vendors Talk Back


By Neil Versel, contributing editor

November 4, 2008 | A month ago, acting Centers for Medicare and Medicaid Services (CMS) administrator Kerry Weems said that physicians can no longer use cost as an excuse for not switching to electronic prescribing. “The business case is turned around,” Weems said citing the affordability of the technology and reasonably small workflow changes it requires.

If the vendor booths at the recent Medical Group Management Association (MGMA) annual meeting were any indication, the promise of 2 percent Medicare bonuses for e-prescribing has captured the attention of doctors and spurred all kinds of interest in health-IT.

“It’s created a sense of urgency that hasn’t been there before,” says Greg White, executive director of health care banking and payer solutions for RelayHealth, a McKesson subsidiary that offers e-prescribing software and services.

Doug Hart, RelayHealth’s senior director of marketing, says e-prescribing gives medical practices more of an advantage than before because it can produce a much faster return on investment than a full electronic medical record, something that is particularly important in this tough economy. Hart reports “lots of interest” in the company’s offering specifically because of the Medicare incentives, but also is seeing inquiries about secure messaging with patients, automation of referrals, appointment scheduling, and the population of personal health records through the RelayHealth user portal.

Starting Jan. 1, physicians can earn an extra 2 percent on top of regular Medicare Part B fees for “successful” e-prescribing. (CMS promises a definition of “successful” as well as detailed rules for the program by Nov. 15.) The bonus falls to 1 percent in 2011, then 0.5 percent in 2013. Meanwhile, those who have not made the switch by 2012 will be subject to penalties. (See “CMS Focuses on E-Prescribing.”)

Since Congress authorized the bonuses with the passage of the Medicare Improvements for Patients and Providers Act in mid-July, Allscripts-Misys Healthcare Solutions, the product of the recently completed merger of ambulatory systems vendors Allscripts Healthcare Solutions and Misys Healthcare Systems, has seen 15 percent monthly growth in the number of e-prescribing customers.

Even though Allscripts offers a free, standalone e-prescribing system through its National ePrescribing Patient Safety Initiative, the Chicago-based company had a lot of interest in complete EMRs from MGMA attendees who saw e-prescribing demos. “It leads to questions about what’s the pathway from e-prescribing to a full EMR,” says Allscripts president and chief operating officer Lee Shapiro.

Similarly, Sage Software Healthcare spokeswoman Lynne Durham says e-prescribing came up in the first 10 conversations she had at the meeting, though much of the interest was in e-prescribing as part of a broader EMR. Sage customers are writing more than 700,000 electronic prescriptions a month, and the majority are from users of the full EMR, Durham reports. “We haven’t seen a lot of rush for the standalone product,” she says.

Eclipsys, a hospital systems vendor that acquired ambulatory IT company MediNotes in October, has had a similar experience. “We’re seeing less interest in standalone e-prescribing than perhaps the buzz was six months ago,” says Thomas R. Cooke, Eclipsys senior vice president of business development.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Coupa white paper 92
10 Secrets to Recession-Proof Your Business
Sponsored by Coupa


Read this white paper to discover 10 strategies smart companies deploy to recession-proof their business.
Leaders generally face hard choices on how to mange a company during an economic downturn and
behave in one of three ways:
1) “The ostrich” - Preserve the status quo/hope for the best
2) “The bull in the china shop” - Blindly cut expenses across the board
3) “The fox” - Use the downturn to make your business more effective and position it for future growth

Learn how to behave “like a fox” and use a recession as a means to pounce on emerging trends.



SGI BriefingON image
High-Performance Computing in Life Science & Education
Sponsored by SGI and Intel
The varied collection of Bio-IT World articles and insights assembled in this BriefingON examine key trends in HPC infrastructure and how researchers are putting their best computational resources to use. Provided here are stories and lessons around the effective use of high performance computing in life science. Download the BriefingON.


Waters white paper image
Software Helps Doping Control Lab Streamline Results Management
Sponsored by Waters
The Karolinska University Hospital’s Doping Control Lab tests thousands of samples annually for stimulants, diuretics, and other masking agents. Increased regulatory pressure and new technologies increased the number of samples analyzed creating data management challenges. Waters® NuGenesis® Scientific Data Management System and TargetLynx™ Application Manager software were used to reduce the time required to calculate, review and search results.


Life Science Webcasts & Podcasts

Medidata Solutions

Rising Clinical Trial Delays and Costs - Addressing the Cause, Not the Symptoms 

medidata podcastProtocol complexity is taking a toll on clinical study speed and efficiency: increasingly complicated and ambitious protocols are not only burdening sites and study volunteers but are also prolonging trials and increasing expenses. In response, sponsors have turned to global study placement, restructured site relationships and new site management practices, but the problem remains.

This podcast will discuss:

  • Why these responses address only the symptoms, not the underlying cause, of rising clinical trial delays and costs.
  • Results of a recent joint Tufts University / Medidata Solutions study.
  • New metrics benchmarking protocol design trends.
  • Systematic protocol design improvements and why they are essential to clinical trial performance excellence.

Speakers: Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Ed Seguine, General Manager, Trial Planning Solutions at Medidata.

Download Now 



More Podcasts

Job Openings

Sequencing Instrument Software Team Leader – Oxford Nanopore Technologies, UK
We are seeking a highly motivated and dynamic individual to join our rapidly growing informatics team, to lead the development of the software and computing subsystem of our revolutionary DNA sequencing system.   The candidate will be required to work to aggressive timelines within an agile development process.   Visit www.nanoporetech.com/vacancies

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.